The New York Eye Cancer Center Results

Combining state-of-the-art treatments with clinical expertise and a human touch, Dr. Finger has achieved a reputation for unparalleled results for his patients.

Palladium-103 Plaque for Interaocular Melanoma

Small, Medium, and Large Tumors:

  • 96.7% local melanoma tumor destruction*
  • 79% better than 20/200 vision for 5 years*
  • 7.3% developed metastasis*

*Statistical Analysis
Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Finger PT, Chin KJ, Duvall G; Palladium-103 for Choroidal Melanoma Study Group. Ophthalmology. 2009 Apr;116(4):790-6

Small “T1” Choroidal Melanoma Treatment

Treated with Palladium-103 Plaque Therapy

  • 72 patients
  • 100% local destruction “control” of the small choroidal melanomas
  • 94.4% kept better than 20/200 vision (with and without anti-VEGF therapy)

Conclusion: Palladium-103 effectively destroyed small choroidal melanomas while preserving functional vision in most patients.

Palladium-103 radiation therapy for small choroidal melanoma. Semenova E, Finger PT. Ophthalmology. 2013 Nov;120(11):2353-7.

Amniotic Membrane for Plaque Radiation Therapy

Dr. Finger was the first to use amniotic membranes to protect the cornea during plaque radiation of iris and ciliary body melanomas.

The Studies:

  • 63 patients with anterior uveal melanoma
  • 95.2% reported no pain during 5-7 days of eye plaque therapy
  • Fewer plaque-related corneal complications
  • Makes treatment much more comfortable

Amniotic Membrane Corneal Buffering During Plaque Radiation Therapy for Anterior Uveal Melanoma. Semenova E, Finger PT. Ophthalmic Surgery Lasers Imaging Retina. 2013;44:477-482.
Fingers’ Amniotic Membrane Buffer Technique: protecting the cornea during radiation plaque therapy. Archives of Ophthalmology 2008;126(4):531-4

Squamous Carcinoma of the Conjunctiva and Cornea

Finger-tip Cryotherapy (with and without topical chemotherapy):

  • 101 squamous cell cancers of conjunctiva and cornea studied for recurrence
  • While overall 12.9% of tumors recurred, only 4% tumors initially treated by Dr. Finger recurred
  • Larger sized, more locally invasive and aggressive tumors are at higher risk for recurrence

Conclusion: Adequate initial therapy reduces the risk for recurrence.

Squamous Carcinoma and Dysplasia of the Conjunctiva and Cornea. Yousef YA, Finger PT. Ophthlamology 2012;119233-240.
Finger-tip cryptherapy probes: treatment of sqaumous and melanocytic conjunctival neoplasia. Finger PT. British Journal of Ophthalology 2005;89(8):942-5

Chemotherapy Eye Drops

Conjunctival Melanoma:

  • Mitomycin: Dr. Finger reported its first use in 1993
  • Treatment of multifocal disease
  • To shrink (debulk) tumors to aid in their removal
  • Currently used around the world

Topical chemotherapy for conjunctival malignant melanoma and primary acquired Melanosis with atypia: 12-year experience. Kurli M, Finger PT. Graefes Archive Clinical Experimental Ophthalmology. 2005;243(11):1108-14.
Topical chemotherapy for conjunctival melanoma. Finger PT, Milner MS, McCormick SA. British Journal of Ophthalmology 1993;77(11)751-3.
Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Finger PT, Sedeek RW, Chin KJ. American Journal of Ophthalmology 2008;145:124-9.

Whole Body PET/CT Imaging: Metastatic Melanoma

Prior to Ocular Treatment:

  • 333 consecutive patients
  • 2.1% had metastases (primarily liver, also bone)
  • 3.3% had unrelated second cancers

Conclusion: PET/CT improves our ability to detect metastasis outside the liver and second non-ocular cancers.

Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients. Freton A, Chin KJ, Raut R, Tena LB, Kivelä T, Finger PT. European Journal of Ophthalmolpgy 2012 Mar-Apr;22(2):236-43.

Preserving Vision after Plaque Radiation Therapy

Dr. Finger first used anti-VEGF therapy for radiation retinopathy. It is now commonly used around the world.

  • 120 patients were studied over 10 years
  • All diagnosed with progressive radiation damage to their retina
  • With anti-VEGF therapy, 80% maintained two lines or better than their initial vision

Conclusion: This study found that decreased treatment intervals and increased dose of anti-VEGF medication was required to suppress radiation retinopathy and maintain vision.

Intravitreal Anti-VEGF Therapy for Macular Radiation Retinopathy: A 10-Year Study. Finger PT, Chin KJ, Semenova E. Eur J Ophthal. In Press.
Anti-vascular endothelial growth factor (avastin) for radiation retinopathy. Finger PT, Chin K. Archives of Ophthalmology 2007;125(6):751-6

Iris Tumor Biopsy: New, Safe and Effective Method

The Finger Iridectomy Technique:

  • 56 successful biopsies of anterior segment tumors
  • No loss of vision
  • 11.5% had transient increase in intraocular pressure
  • No infections or cataracts

Conclusions: Patients experienced fewer hemorrhages and less overall side effects than with standard biopsy (iridectomy).

Anterior Segment Tumor Biopsy Using an Aspiration Cutter Technique: Clinical Experience. Petousis V, Finger PT, Milman T. American Journal of Ophthalmology 2011;152:771-775
The Finger Iridectomy Technique: small incision biopsy of anterior segment tumors. Finger PT, Latkany P, Kurli M, Iacob C. British Journal of Ophthalmology 2005;89(8):946-9.

Minimally Invasive Biopsy of Orbital Tumors

Pilot Study:

  • Three patients underwent orbital tumor biopsy via Finger’s aspiration cutter technique (FACT) through a 3mm incision
  • FACT orbital biopsy may be used for metastatic tumors, inflammation, infections and hematomas.

Conclusion: FACT is a new and effective diagnostic surgery with the advantage of being minimally invasive compared to standard orbital biopsy techniques.

Minimally invasive anterior orbitotomy biopsy: Finger’s aspiration cutter technique (FACT). Finger PT. European Journal Ophthalmology 2012;22(3):309-15.

Looking Good After Enucleation Surgery

Quality of Life Study:

  • Temporary prosthesis offered at 3-5 days rather than 1 month after surgery
  • 87% tolerated “early” placement of prosthesis

Conclusion: All patients preferred their appearance with temporary prosthesis versus a clear plastic conformer.

Early ocular prosthesis insertion improves quality of life after enucleation. Chin KJ, Margolin CB, Finger PT. Optometry. 2006 Feb;77(2):71-5.

Patient Stories

"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
N.N.

Read More

REQUEST AN APPOINTMENT

  • This field is for validation purposes and should be left unchanged.

CONNECT AND SHARE